The present invention relates to budiodarone formulations which comprise a solution comprising benzyl alcohol and budiodarone, wherein the budiodarone has an aqueous solubility of about 200 mg/ml to about 1250 mg/ml when contacted with an aqueous solution. The budiodarone formulations can be highly concentrated and stored with stability, yet the formulations are also dilutable and can be delivered to a subject with ease and immediacy.